About 20% of 81 positive patients experienced critical neurological complications; further, half had a pre-existing history of high blood pressure or type 2 diabetes.
A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.
A panel of experts in schizophrenic psychiatric care share their thoughts on the practice, patients, and treatment based on their years of experience.
Elizabeth A. Swanson, MD, and Raj. J. Chovatiya, MD, PhD, examine challenges in managing atopic dermatitis and explore the evolving treatment landscape.
A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.
Experts in dermatology review how JAK inhibitors will impact dermatology care across the board.
Kim Zuber, PA-C, and Jane Davis, DNP, provide perspective on guideline recommendations for the management of hepatitis C in people with chronic kidney disease from the Kidney Disease Improving Global Outcomes.
The inhibition of Janus kinase to prevent downstream signaling of proinflammatory cytokines has been shown to be a novel method of treating ulcerative colitis.
Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri share takeaway thoughts on the management of nasal polyposis.
A panel of experts in schizophrenic psychiatric care share their thoughts on the practice, patients, and treatment based on their years of experience.
Results of a recent study showed that the risk of pneumocystis jiroveci pneumonia (PJP) is low in patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR), therefore discouraging the routine prescribing of PJP prophylaxis for this patient population.
A review of changes to clinical, dietary and screening strategies for patients with GERD.
Concluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.
An expert panel shares insight on the future treatment landscape for treatment-resistant depression.
Carl Regillo, MD and Diana Do, MD react to newer therapies being explored for wet AMD and discuss their place in future therapeutic algorithms.
Experts in dermatology share practice pearls to advanced practice providers and community dermatologists for the management of plaque psoriasis.
High blood pressure and low fitness levels were each associated with an increased risk of CVD mortality independently of established and emerging risk factors in new findings.
In this program, we will engage in discussions with a vitiligo patient to explore the impact of the condition on their daily lives, the challenges they face with treatment, and how they manage expectations related to living with vitiligo.
Drs Raj Chovatiya, George Han, and Vivian Shi review the current challenges and opportunities surrounding the utilization and availability of biologic therapies in atopic dermatitis.
Experts in pediatric hepatology share advice for the optimal management of Alagille syndrome.
Jessica Allegretti, MD, MPH, and Edward Loftus Jr., MD, review emerging agents in the later phases for the management of IBD.
An expert panel shares insight on the future treatment landscape for treatment-resistant depression.
Carl Regillo, MD and Diana Do, MD react to newer therapies being explored for wet AMD and discuss their place in future therapeutic algorithms.
Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Adam Friedman, MD, FAAD discusses how payors accelerated non-medical switching during COVID-19 and how healthcare providers can respond to new challenges.